Telemedicine follow-up for early laryngeal cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of Telemedicine follow-up as an alternative to traditional in-person follow-up care for patients treated for early glottic cancer. It compares patient satisfaction and safety outcomes, such as recurrence rates and complications, between those receiving Telemedicine follow-up and those receiving standard care at a specialized head and neck oncology center. Participants are randomly assigned based on their travel distance to the center, with the aim of determining if remote evaluations can maintain quality care for patients living far from specialized facilities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients who underwent TOLS for early stage glottic squamous cell carcinoma (T1 or carcinoma-in-situ)
* a one-way travel time to the HNOC of ≥45 minutes (intervention group) or \< 30 minutes (control group)
* within 2 years postoperatively
* can speak and write Dutch

Exclusion Criteria:

* Patients will be excluded if they continue to undergo follow-up for other (head and neck) cancers in the HNOC.

Where it's running

• University Medical Center Groningen
  Groningen, Provincie Groningen, Netherlands Recruiting

Study contacts

• Principal investigator: Boudewijn E.C. Plaat, MD, PhD — UMC Groningen
• Study coordinator: Nathalie F van Rhee, MD
• Email: n.f.van.rhee@umcg.nl
• Phone: +31614915058

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intraoperative Methadone for Postoperative Pain in Head and Neck Cancer Patients

  This trial tests whether giving methadone during surgery, in addition to standard fentanyl, helps control pain after head and neck cancer surgery more effectively than fentanyl alone.

  Recruiting Phase 4 OHSU Knight Cancer Institute · Portland, Oregon · NCT07857655

• Cough Skill Training to Help Head and Neck Cancer Patients Recover Voluntary Cough

  Researchers will test whether a handheld cough device-based training can help people with head and neck cancer improve their voluntary cough function.

  Recruiting Boston University Charles River Campus · Boston, Massachusetts · NCT07756684

• Mild heat therapy added to standard treatment for locally advanced head and neck cancer

  This early-stage trial tests whether mild hyperthermia can be safely added to standard radiotherapy with or without chemotherapy for locally advanced head and neck cancer.

  Recruiting Phase 1 Erasmus Medical Center · Rotterdam, South Holland · NCT07690618

• HMB Supplements to See If they Help Inflammation and Recovery After Head and Neck Cancer Surgery

  This study tests whether taking HMB before surgery can reduce inflammation and improve recovery for adults with head and neck cancer undergoing tumor removal.

  Recruiting Federal University of Minas Gerais · Belo Horizonte, Minas Gerais · NCT07675421

• Dietary fiber and sarcopenia risk in head and neck cancer

  This observational study will track fiber intake and related biological markers in adults with head and neck cancer from diagnosis for six months to see if higher fiber intake relates to better muscle health and lower inflammation during treatment.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07622914

• EPI-326 for EGFR-mutant non-small cell lung cancer and head and neck squamous cell carcinoma

  This phase 1 trial will try EPI-326, a new drug, in people with EGFR-mutant non‑small cell lung cancer or advanced head and neck squamous cell carcinoma to find safe doses, study how the body handles it, and look for early signs it shrinks tumors.

  Recruiting at 8 sites Phase 1 EpiBiologics · Los Angeles, California and 7 other locations · NCT07462377

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.